Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""United States Food and Drug Administration"" wg kryterium: Temat


Tytuł:
Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.
Autorzy:
Li Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.
Wang X; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.
Liao Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.
Zeng Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.
Lin W; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.
Zhuang W; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 May 09; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 May 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dibenzothiepins*/adverse effects
Triazines*/adverse effects
Oseltamivir*/adverse effects
Antiviral Agents*/adverse effects
United States Food and Drug Administration*
Morpholines*/adverse effects
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems*/statistics & numerical data
Humans ; United States ; Female ; Male ; Adult ; Middle Aged ; Adolescent ; Pyridones/adverse effects ; Young Adult ; Aged ; Influenza, Human/drug therapy ; Child ; Triazoles/adverse effects ; Thiepins/adverse effects ; Pyrazines/adverse effects ; Pyridines/adverse effects ; Child, Preschool ; Oxazines/adverse effects
Czasopismo naukowe
Tytuł:
FDA's proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States.
Autorzy:
Paniz-Mondolfi AE; Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Ramírez JD; Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 May 09; Vol. 18 (5), pp. e0012116. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neglected Diseases*/epidemiology
United States Food and Drug Administration*/legislation & jurisprudence
Communicable Diseases, Emerging*/epidemiology
United States/epidemiology ; Humans ; Tropical Medicine
Czasopismo naukowe
Tytuł:
Clarification of Information in "Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance Tests".
Autorzy:
Lockwood CM; Department of Laboratory Medicine and Pathology, University of Washington Medicine, Seattle.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 May 01; Vol. 148 (5), pp. 507.
Typ publikacji:
Letter; Journal Article
MeSH Terms:
United States Food and Drug Administration*
High-Throughput Nucleotide Sequencing*
Laboratory Proficiency Testing*
United States ; Humans ; Laboratories, Clinical
Czasopismo naukowe
Tytuł:
Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system.
Autorzy:
Zhang X; Department of Pharmacy, Suining Central Hospital, No.127, West Desheng Road, Chuanshan District, Suining, 629000, Sichuan, People's Republic of China.
Xia L; Cancer Center of Suining Central Hospital, Suining, 629000, Sichuan, People's Republic of China.
Yang Q; Department of Pharmacy, Suining Central Hospital, No.127, West Desheng Road, Chuanshan District, Suining, 629000, Sichuan, People's Republic of China.
Tang P; Department of Pharmacy, Suining Central Hospital, No.127, West Desheng Road, Chuanshan District, Suining, 629000, Sichuan, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 28; Vol. 14 (1), pp. 9743. Date of Electronic Publication: 2024 Apr 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
United States Food and Drug Administration*
Hearing Loss*/chemically induced
Hearing Loss*/epidemiology
Phosphodiesterase 5 Inhibitors*/adverse effects
Adverse Drug Reaction Reporting Systems*/statistics & numerical data
Humans ; United States/epidemiology ; Male ; Middle Aged ; Female ; Aged ; Adult ; Databases, Factual
Czasopismo naukowe
Tytuł:
An empirical analysis of overall survival in drug approvals by the US FDA (2006-2023).
Autorzy:
Elbaz J; Hofstra University, Hempstead, New York, USA.
Haslam A; University of California San Francisco, San Francisco, California, USA.
Prasad V; University of California San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7190.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Approval*/statistics & numerical data
United States Food and Drug Administration*
Antineoplastic Agents*/therapeutic use
United States ; Humans ; Neoplasms/drug therapy ; Neoplasms/mortality ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
'Damning' FDA inspection report undermines Alzheimer's drug.
Autorzy:
Piller C
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1165-1166. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Wiadomości
MeSH Terms:
Alzheimer Disease*/drug therapy
Scientific Misconduct*
Spiro Compounds*/therapeutic use
United States Food and Drug Administration*
Humans ; United States ; Clinical Trials as Topic
Periodyk
Tytuł:
Mechanism of action, potency and efficacy: considerations for cell therapies.
Autorzy:
Simon CG Jr; Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, USA. .
Bozenhardt EH; United Therapeutics Corporation, Regenerative Medicine Operations, Research Triangle Park, NC, USA.
Celluzzi CM; Association for the Advancement of Blood and Biotherapies (AABB), Bethesda, MD, USA.
Dobnik D; Niba Labs, Ljubljana, Slovenia.; National Institute of Biology, Ljubljana, Slovenia.
Grant ML; Department of Pediatrics, Children's Healthcare of Atlanta, Marcus Center for Cellular and Gene Therapies, Correlative Studies Laboratory, Emory University School of Medicine, Atlanta, GA, USA.
Lakshmipathy U; Pharma Services, Science and Technology, Thermo Fisher Scientific, San Diego, CA, USA.
Nebel T; Medical Education, Sports Medicine and Orthobiologics, Medical Sales Institute, San Diego, CA, USA.
Peltier L; Cellular Therapy Lab, Research Institute of McGill University Health Center, Montreal, QC, Canada.
Ratcliffe A; Synthasome, Inc, San Diego, CA, USA.
Sherley JL; Asymmetrex, LLC, Boston, MA, USA.
Stacey GN; International Stem Cell Banking Initiative, Barley, Herts, UK.; National Stem Cell Resource Centre, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Beijing Institute for Stem Cells and Regenerative Medicine, Chinese Academy of Sciences, Beijing, China.
Taghizadeh RR; Kendall Innovations, Cambridge, MA, USA.
Tan EHP; Cell and Gene Therapy Facility, Health Sciences Authority, Singapore, Singapore.
Vessillier S; Science, Research and Innovation Group, Biotherapeutics and Advanced Therapies Division, Medicines and Healthcare Products Regulatory Agency, South Mimms, Hertfordshire, UK.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 May 02; Vol. 22 (1), pp. 416. Date of Electronic Publication: 2024 May 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cell- and Tissue-Based Therapy*/methods
Humans ; Animals ; Treatment Outcome ; United States Food and Drug Administration ; United States ; Clinical Trials as Topic
Czasopismo naukowe
Tytuł:
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act.
Autorzy:
Feldman R; University of California Law, San Francisco, California, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2024 Apr 25; Vol. 21 (4), pp. e1004381. Date of Electronic Publication: 2024 Apr 25 (Print Publication: 2024).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Intellectual Property*
Biosimilar Pharmaceuticals*
United States ; Humans ; Biological Products ; Patents as Topic/legislation & jurisprudence ; Legislation, Drug ; United States Food and Drug Administration/legislation & jurisprudence
Czasopismo naukowe
Tytuł:
Utah flouts FDA with new placental stem cell law.
Autorzy:
Wadman M
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Apr 05; Vol. 384 (6691), pp. 14-15. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Wiadomości
MeSH Terms:
Placenta*/cytology
Stem Cell Transplantation*/legislation & jurisprudence
Stem Cells*/cytology
Female ; Humans ; Pregnancy ; United States Food and Drug Administration ; Utah
Periodyk
Tytuł:
Analysis of post-market adverse events of istradefylline: a real-world study base on FAERS database.
Autorzy:
Jiang Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, 214151, Jiangsu, China.
Lu R; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, 214151, Jiangsu, China.
Zhou Q; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, 214151, Jiangsu, China.
Shen Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, 214151, Jiangsu, China. .
Zhu H; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, 214151, Jiangsu, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7659. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Compulsive Behavior*
Purines*/adverse effects
United States ; Databases, Factual ; Drug Evaluation, Preclinical ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł:
Postmarket safety communications on drugs approved in Japan: A 25-year analysis.
Autorzy:
Tanaka Y; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Tanaka M; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Miyazawa H; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Terashima R; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Miyazawa M; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Ikuma M; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.; Office of Pharmacovigilance, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Tomita Y; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13803.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Approval*
Product Surveillance, Postmarketing*/statistics & numerical data
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Japan ; Humans ; Retrospective Studies ; United States Food and Drug Administration/standards ; Drug Labeling/standards ; United States ; Adverse Drug Reaction Reporting Systems/statistics & numerical data
Czasopismo naukowe
Tytuł:
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication.
Autorzy:
Sever B; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Türkiye.; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Otsuka M; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.; Department of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan.
Fujita M; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Ciftci H; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.; Department of Drug Discovery, Science Farm Ltd., Kumamoto 862-0976, Japan.; Department of Bioengineering Sciences, Izmir Katip Celebi University, Izmir 35620, Türkiye.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 25; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV-1*
Acquired Immunodeficiency Syndrome*
United States ; Humans ; United States Food and Drug Administration ; Apoptosis ; Cell Division
Czasopismo naukowe
Tytuł:
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.
Autorzy:
Liu K; Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Li M; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Li Y; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Li Y; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Chen Z; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Tang Y; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Yang M; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Deng G; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.
Liu H; Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China. .; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 23; Vol. 23 (1), pp. 62. Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunoconjugates*/therapeutic use
Neoplasms*/drug therapy
Neoplasms*/pathology
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
United States ; Humans ; United States Food and Drug Administration ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Amidst spreading infectious diseases and climate change, US FDA should renew its focus on neglected tropical diseases.
Autorzy:
Berger M; US Federal Government, Rockville, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Mar 21; Vol. 18 (3), pp. e0012005. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Communicable Diseases*/epidemiology
Tropical Medicine*
United States/epidemiology ; Humans ; Climate Change ; Neglected Diseases/epidemiology ; Neglected Diseases/prevention & control ; United States Food and Drug Administration ; Tropical Climate
Czasopismo naukowe
Tytuł:
Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis.
Autorzy:
She X; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Yin D; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Guo Q; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Tang Y; Department of Pharmacy, School of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
Wang S; Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. .
Wang X; Central Laboratory, Shanxi Hospital of Integrated Traditional Chinese and Western Medicine, Taiyuan, Shanxi, People's Republic of China. .; Key Laboratory of Research and Development of Traditional Chinese Medicine Preparations, Taiyuan, Shanxi, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5592. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Anilides*
Carcinoma, Renal Cell*/drug therapy
Indazoles*
Kidney Neoplasms*/pathology
Phenylurea Compounds*
Pyridines*
Pyrimidines*
Quinolines*
Sulfonamides*
Aged ; Humans ; Male ; Axitinib/therapeutic use ; Bayes Theorem ; Electrolytes ; Pharmacovigilance ; Retrospective Studies ; Sorafenib/adverse effects ; Sunitinib/adverse effects ; United States ; United States Food and Drug Administration ; Female ; Middle Aged
Czasopismo naukowe
Tytuł:
Exploration of adverse events associated with risdiplam use: Retrospective cases from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Autorzy:
Yu L; College of Traditional Chinese Medicine of Chongqing Medical University, Chongqing, China.
Liu L; Pharmacy Department of Chongqing YouYou BaoBei Women's and Children's Hospital, Chongqing, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 01; Vol. 19 (3), pp. e0298609. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Muscular Atrophy, Spinal*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Pyrimidines*
United States/epidemiology ; Humans ; Retrospective Studies ; United States Food and Drug Administration ; Azo Compounds ; Databases, Factual ; Pharmacovigilance ; Adverse Drug Reaction Reporting Systems
Czasopismo naukowe
Tytuł:
Analysis of the first ten years of FDA's rare pediatric disease priority review voucher program: designations, diseases, and drug development.
Autorzy:
Mease C; Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA. .
Miller KL; Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Fermaglich LJ; Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Best J; Office of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Liu G; Office of Therapeutic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Torjusen E; Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 25; Vol. 19 (1), pp. 86. Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/drug therapy
Rare Diseases*/drug therapy
Child ; Humans ; Infant, Newborn ; Drug Approval ; Drug Development ; Orphan Drug Production ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł:
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
Autorzy:
Al Musaimi O; School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.; Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 22; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adrenocorticotropic Hormone*
alpha-MSH*/pharmacology
United States ; Cholecystokinin ; Glucagon-Like Peptide 1 ; United States Food and Drug Administration ; Melanocyte-Stimulating Hormones ; Transcription Factors
Czasopismo naukowe
Tytuł:
Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022.
Autorzy:
Seoane-Vazquez E; Department of Pharmaceutical Economic and Policy, Chapman University School of Pharmacy, Irvine, CA, USA. .; Economic Science Institute, Argyros School of Business and Economics, Chapman University, Orange, CA, USA. .
Rodriguez-Monguio R; Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, USA.; Medication Outcomes Center, University of California San Francisco, San Francisco, USA.; Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, USA.
Powers JH 3rd; Department of Medicine, George Washington University School of Medicine, Washington, DC, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3325. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Orphan Drug Production*
Biological Products*/therapeutic use
United States ; Humans ; United States Food and Drug Administration ; Pharmaceutical Preparations ; Biological Factors ; Drug Approval
Czasopismo naukowe
Tytuł:
Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance.
Autorzy:
Harada S; From the Department of Pathology, The University of Alabama, Birmingham.
Mackinnon AC; From the Department of Pathology, The University of Alabama, Birmingham.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Feb 01; Vol. 148 (2), pp. 136-138.
Typ publikacji:
Journal Article
MeSH Terms:
Laboratories, Clinical*
Clinical Laboratory Services*
United States ; Humans ; United States Food and Drug Administration ; Laboratories ; High-Throughput Nucleotide Sequencing ; Laboratory Proficiency Testing
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies